Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. ACN
3. NVDA
4. USO
5. GOOGL
6. APGE
7. MU
8. HOOD
9. DFTX
10. MSFT

Go back to Galectin Therapeutics Reports Third Quarter 2015 Financial Results and Provides Business Update

Galectin Therapeutics (GALT) Misses Q3 EPS by 6c

November 9, 2015 8:04 AM EST

Galectin Therapeutics (NASDAQ: GALT) reported Q3 EPS of ($0.26), $0.06 worse than the analyst estimate of ($0.20).

For earnings history and earnings-related data on Galectin Therapeutics (GALT) click here.

... More